Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments division of Essilor International, a subsidiary of EssilorLuxottica. Essilor International is the world’s leading ophthalmic optics… Continue reading Diagnos $ADK #DGNOF Signs Memorandum of Understanding with #Essilor International
Category: Diagnos
Diagnos $ADK $DGNOF Announces the Opening of the #AI Assisted #Screening #Clinic at #Magrabi #Hospital with the Presence of the Undersecretary of the Ministry of #Health of #SaudiArabia
Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the early detection unit… Continue reading Diagnos $ADK $DGNOF Announces the Opening of the #AI Assisted #Screening #Clinic at #Magrabi #Hospital with the Presence of the Undersecretary of the Ministry of #Health of #SaudiArabia
Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in… Continue reading Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE
Diagnos $ADK $DGNOF Announces Pilot with Sinaloa Hospital
Diagnos (TSXV-ADK) (OTCQB-DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest ophthalmological hospital in Sinaloa State, Mexico. In Mexico there are 18 million diabetics with a 23% prevalence in people of 20 years or more; the seriousness of these cases is… Continue reading Diagnos $ADK $DGNOF Announces Pilot with Sinaloa Hospital
Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), BROSSARD, Quebec, June 09, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena… Continue reading Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the signing of a multi-year agreement with IRIS The Visual Group (1990) Inc. (“IRIS”), creating a world leading platform launch for the deployment and enhancement of Artificial Intelligence (“AI”) based tests, screening for… Continue reading Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. $ADK $DGNOF #Interview with InvestorIntel – #AI #Healthcare #Technology for #Diabetic #BlindnessPrevention
Diagnos Inc. $ADK $DGNOF #AI #healthcare #technology #diabetics #blindness #StrokePrevention Interview: https://youtu.be/B7elDQ7bgb4 InvestorIntel Interview with Andre Larente, President of Diagnos Inc.
Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
Diagnos Inc. TSXV-ADK OTCQB: DGNOF a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH (“Diagnos Europe”), a new partner for DIAGNOS to tackle the strategically important DACH countries in the European… Continue reading Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
@Diagnos $ADK $DGNOF Uses #AI and #Telemedicine to Scan your #Eye for #Health Issues in 16 Countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal… Continue reading @Diagnos $ADK $DGNOF Uses #AI and #Telemedicine to Scan your #Eye for #Health Issues in 16 Countries
Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology
Diagnos Inc. $ADK and the 3rd Largest #optical Retailer in Costa Rica Piloting CARA and its #telemedicine #technology #Healthcare #diabetes #retinaldisease #AI #artificialintelligence #Hypertension #stroke #deeplearning https://www.globenewswire.com/news-release/2021/03/04/2187355/0/en/DIAGNOS-and-the-third-largest-optical-retailer-in-Costa-Rica-Piloting-CARA-and-its-Telemedicine-technology.html Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based… Continue reading Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology